Eugene N.
- Country
- Ireland
- Department
- Ophtalmology
Research Overview
- Phase 3 Randomized Controlled Trial of Vitrectomy, Subretinal Alteplase, and Intravitreal Aflibercept for Submacular Hemorrhage in Exudative Age-Related Macular Degeneration
- Efficacy and Safety Evaluation of GAL-101 Ophthalmic Solution in Non-Foveal Geographic Atrophy Secondary to Non-Neovascular Age-Related Macular Degeneration
Data & Insights
Has run more than one trial at 2 of 34 partner sites.
Specializations
Ophthalmology
The investigator specializes in advanced treatments for age-related macular degeneration (AMD), with particular emphasis on managing complex cases involving submacular hemorrhage.
- Exudative AMD Management
- Retinal Surgery Techniques
- Vitreoretinal Interventions
Their expertise extends to innovative surgical approaches combining vitrectomy procedures with targeted therapeutic interventions for retinal conditions.
Surgical Innovation
The investigator focuses on developing enhanced surgical protocols for subretinal treatments, particularly in cases requiring precise medication delivery systems.
- Advanced Vitrectomy Techniques
- Subretinal Drug Administration
- Gas Tamponade Procedures
Their work encompasses the integration of multiple treatment modalities for complex retinal conditions.
Therapeutic Applications
The investigator explores combinations of surgical and pharmacological interventions for treating advanced retinal disorders.
- Anti-VEGF Therapy
- Tissue Plasminogen Activator Applications
- Combined Treatment Approaches
Their focus includes the development of treatment protocols for complex retinal hemorrhages in AMD patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.